[1]
Homma, Y. et al. 2025. Prognostic Significance of Post-Neoadjuvant Chemotherapy Carbohydrate Antigen 19-9 Levels in Patients With Resectable Pancreatic Cancer Treated With S-1 and Gemcitabine: A Retrospective Cohort Study. World Journal of Oncology. 16, 3 (Jun. 2025), 269–275. DOI:https://doi.org/10.14740/wjon2563.